DLA Piper's Global M&A intelligence report Lanuch
Published on 26/05/2023
The DLA Piper Life Sciences sector team is delighted to announce the launch of our new 2023 Global M&A Intelligence Report – Life Sciences Supplement.The Supplement – created by M&A professionals from across our global Life Sciences sector team – covers M&A deal activity in 2022 and supplements our 2023 global M&A Intelligence Report, which is now in its ninth edition.
The report looks at a selection of our international corporate life sciences transactions to identify trends and developments, which can provide insightful intelligence for those operating in the sector and considering M&A activity, both domestically or internationally.
We hope that you find this report to be a useful resource.
